Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PDE4DIP pseudogene 3 is a non-functional genomic fragment related to the PDE4DIP (Phosphodiesterase 4D interacting protein, myomegalin) gene. Pseudogenes are typically unable to encode functional proteins due to disabling mutations and are not considered druggable targets[7]. PDE4DIP pseudogene 3 does not have a defined role in biology or disease and should not be confused with the functional PDE4DIP gene product, which is involved in cellular scaffolding and signal transduction[1][2][5]. There are no therapeutic compounds, disease roles, or validated functions associated with PDE4DIP pseudogene 3. Key Note: If you meant to refer to the protein-coding PDE4DIP gene (phosphodiesterase 4D interacting protein, myomegalin), that is a characterized protein involved in the anchoring of PDE4D and modulation of cell migration, microtubule organization, and signal transduction. The pseudogene has no such roles and is not a relevant molecular target[1][2][4].
Not a drug target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PDE4DIP pseudogene 3 (PDE4DIPP3).